0
Skip to Content
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Pharma 2/6/15 Pharma 2/6/15

Pfizer and Hospira: It's not about generics

Read More
Health plans, Pharma 1/13/15 Health plans, Pharma 1/13/15

Hepatitis C drug battle. What's going on?

Read More
Announcements, Pharma, Policy and politics 1/12/15 Announcements, Pharma, Policy and politics 1/12/15

Hepatitis C drug battle: I'm quoted

Read More
Announcements, Patients, Pharma, Policy and politics, Research 12/17/14 Announcements, Patients, Pharma, Policy and politics, Research 12/17/14

In praise of FDA collaboration: the cardiac safety example

Read More
Pharma, Policy and politics 11/6/14 Pharma, Policy and politics 11/6/14

CVS: Drugs, tobacco... and guns?

Read More
Pharma, Policy and politics 8/13/14 Pharma, Policy and politics 8/13/14

Consumer Reports lets us down with attack on Zohydro ER

Read More
Health plans, Pharma, Policy and politics 8/7/14 Health plans, Pharma, Policy and politics 8/7/14

Whining about the thousand-dollar pill

Read More
Entrepreneurs, Hospitals, Pharma, Physicians, Podcast 7/8/14 Entrepreneurs, Hospitals, Pharma, Physicians, Podcast 7/8/14

Provider engagement: Quantia touts the key to unlock health system and pharma success

Read More
Patients, Pharma, Policy and politics 5/4/14 Patients, Pharma, Policy and politics 5/4/14

Guest post: We Must Change the Way We View Addiction

Read More
Pharma, Policy and politics, Research 4/24/14 Pharma, Policy and politics, Research 4/24/14

Venture capital fantasyland: Venrock's proposal to reform drug development

Read More
Pharma, Policy and politics 4/15/14 Pharma, Policy and politics 4/15/14

Zohydro ban: Disagreeing with Governor Patrick

Read More
Health plans, Patients, Pharma, Policy and politics 4/7/14 Health plans, Patients, Pharma, Policy and politics 4/7/14

Should step therapy and prior authorization be outlawed?

Read More
Pharma, Physicians, Podcast, Policy and politics 4/2/14 Pharma, Physicians, Podcast, Policy and politics 4/2/14

Office of Recovery: Avellone proposes strong response to substance abuse (transcript)

Read More
Health plans, Patients, Pharma, Policy and politics 4/1/14 Health plans, Patients, Pharma, Policy and politics 4/1/14

Hooray for high-priced hepatitis treatment Sovaldi

Read More
Pharma, Physicians, Podcast, Policy and politics 3/26/14 Pharma, Physicians, Podcast, Policy and politics 3/26/14

Office of Recovery: Avellone proposes strong response to substance abuse

Read More
Economics, Pharma, Policy and politics 1/24/14 Economics, Pharma, Policy and politics 1/24/14

A better business model for antibiotics

Read More
Pharma, Policy and politics 1/10/14 Pharma, Policy and politics 1/10/14

Marijuana legalization: Con and pro

Read More
Pharma 10/9/13 Pharma 10/9/13

Like I said: Advair Diskus too hard to copy

Read More
Devices, Pharma 9/16/13 Devices, Pharma 9/16/13

How a tough manufacturing process for Advair might help GSK

Read More
Culture, Pharma, Research 9/5/13 Culture, Pharma, Research 9/5/13

Rerun: What the Talmud teaches about drug company gifts to doctors

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2024 Health Business Group. All Rights Reserved.